{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T16:27:33Z","timestamp":1778948853941,"version":"3.51.4"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,5,15]],"date-time":"2007-05-15T00:00:00Z","timestamp":1179187200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2007,8,22]]},"DOI":"10.1007\/s12032-007-0002-3","type":"journal-article","created":{"date-parts":[[2007,5,14]],"date-time":"2007-05-14T16:00:48Z","timestamp":1179158448000},"page":"354-356","source":"Crossref","is-referenced-by-count":5,"title":["Relapse of preB-ALL after rituximab treatment for chronic graft versus host disease. Implications for its use?"],"prefix":"10.1007","volume":"24","author":[{"given":"Stefan","family":"Deneberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Lerner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Ljungman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olle","family":"Ringden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"H\u00e4gglund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,5,15]]},"reference":[{"issue":"12","key":"2_CR1","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/sj.bmt.1704974","volume":"35","author":"H Hallbook","year":"2005","unstructured":"Hallbook H, Hagglund H, Stockelberg D, Swedish Adult ALL Group et al. Autologous and allogeneic stem cell transplantation in adult ALL: the Swedish Adult ALL Group experience. Bone Marrow Transplant 2005;35(12):1141\u20138.","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"2_CR2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bbmt.2003.11.002","volume":"10","author":"A Nordlander","year":"2004","unstructured":"Nordlander A, Mattsson J, Ringden O, et al. Graft-versus-host disease is associated with a lower relapse incidence after hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia. Biol Blood Marrow Transplant 2004;10(3):195\u2013203.","journal-title":"Biol Blood Marrow Transplant"},{"key":"2_CR3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/sj.bmt.1701064","volume":"21","author":"JR Passweg","year":"1998","unstructured":"Passweg JR, Tiberghien P, Cahn JY, et al. Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia. Bone Marrow Transplant 1998;21:153\u20138.","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 4","key":"2_CR4","first-page":"S15","volume":"11","author":"FR Appelbaum","year":"1997","unstructured":"Appelbaum FR, et al. Graft versus leukaemia (GVL) in the therapy of acute lymphoblastic leukaemia (ALL). Leukemia 1997;11(Suppl 4):S15\u20137.","journal-title":"Leukemia"},{"issue":"6","key":"2_CR5","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/01.moh.0000245689.47333.ff","volume":"13","author":"K Baird","year":"2006","unstructured":"Baird K, Pavletic SZ. Chronic graft versus host disease. Curr Opin Hematol 2006;13(6):426\u201335.","journal-title":"Curr Opin Hematol"},{"issue":"6","key":"2_CR6","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/00001622-199811000-00012","volume":"10","author":"GA Leget","year":"1998","unstructured":"Leget GA, Czuczman MS. Use of rituximab, the new FDA-approved antibody. Curr Opin Oncol 1998;10(6):548\u201351.","journal-title":"Curr Opin Oncol"},{"issue":"3","key":"2_CR7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.4065\/81.3.377","volume":"81","author":"RH. Carter","year":"2006","unstructured":"Carter RH. B cells in health and disease. Mayo Clin Proc 2006;81(3):377\u201384.","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"2_CR8","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood-2006-01-0233","volume":"108","author":"C Cutler","year":"2006","unstructured":"Cutler C, Miklos D, Kim HT, et al. Rituximab for steroid-refractory chronic graft-versus-host disease. Blood 2006;108(2):756\u201362. Epub 2006 Mar 21.","journal-title":"Blood"},{"key":"2_CR9","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S1083-8791(03)00216-7","volume":"9","author":"V Ratanatharathorn","year":"2003","unstructured":"Ratanatharathorn V, Ayash L, Reynolds C, et al. Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody. Biol Blood Marrow Transplant 2003;9:505\u201311.","journal-title":"Biol Blood Marrow Transplant"},{"key":"2_CR10","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1182\/blood-2004-05-1855","volume":"104","author":"MR Canninga-van Dijk","year":"2004","unstructured":"Canninga-van Dijk MR, van der Straaten HM, Fijnheer R, et al. Anti-CD20 monoclonal antibody treatment in 6 patients with therapy-refractory chronic graft-versus-host disease. Blood 2004;104:2603\u20136.","journal-title":"Blood"},{"issue":"1","key":"2_CR11","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/sj.leu.2403996","volume":"20","author":"M Okamoto","year":"2006","unstructured":"Okamoto M, Okano A, Akamatsu S, et al. Rituximab is effective for steroid-refractory sclerodermatous chronic graft-versus-host disease. Leukemia 2006;20(1):172\u20133.","journal-title":"Leukemia"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-007-0002-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-007-0002-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-007-0002-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T02:25:20Z","timestamp":1559442320000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-007-0002-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,15]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,8,22]]}},"alternative-id":["2"],"URL":"https:\/\/doi.org\/10.1007\/s12032-007-0002-3","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,15]]}}}